NRBF2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.264200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.578200E-01
Normal-vs-Stage2
7.033600E-01
Normal-vs-Stage3
5.490000E-01
Normal-vs-Stage4
6.354600E-01
Stage1-vs-Stage2
3.654400E-01
Stage1-vs-Stage3
7.742600E-01
Stage1-vs-Stage4
2.127200E-01
Stage2-vs-Stage3
7.189200E-01
Stage2-vs-Stage4
2.114600E-01
Stage3-vs-Stage4
3.800600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.920000E-01
Normal-vs-AfricanAmerican
8.743000E-01
Normal-vs-Asian
6.907600E-01
Caucasian-vs-AfricanAmerican
6.208200E-01
Caucasian-vs-Asian
7.536400E-01
AfricanAmerican-vs-Asian
8.218000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.085200E-01
Normal-vs-Female
6.621200E-01
Male-vs-Female
6.369000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.402600E-01
Normal-vs-Age(41-60Yrs)
8.628800E-01
Normal-vs-Age(61-80Yrs)
4.486200E-01
Normal-vs-Age(81-100Yrs)
2.777400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.495240E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.080400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.819200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.156850E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.393700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.358400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.234800E-01
Normal-vs-Daily Drinker
2.754200E-01
Normal-vs-Weekly Drinker
8.712600E-01
Normal-vs-Occasional Drinker
7.757000E-01
Normal-vs-Social Drinker
7.253000E-01
Non Drinker-vs-Daily Drinker
5.161200E-01
Non Drinker-vs-Weekly Drinker
2.258400E-01
Non Drinker-vs-Occasional Drinker
2.968800E-01
Non Drinker-vs-Social Drinker
4.098800E-01
Daily Drinker-vs-Weekly Drinker
9.163900E-02
Daily Drinker-vs-Occasional Drinker
1.204600E-01
Daily Drinker-vs-Social Drinker
1.885010E-01
Weekly Drinker-vs-Occasional Drinker
8.212200E-01
Weekly Drinker-vs-Social Drinker
7.297400E-01
Occasional Drinker-vs-Social Drinker
8.902800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.827000E-01
Normal-vs-Grade 2
5.476000E-01
Normal-vs-Grade 3
9.902400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.92530000000724E-05
Grade 1-vs-Grade 3
3.458800E-03
Grade 1-vs-Grade 4
4.827000E-01
Grade 2-vs-Grade 3
5.498400E-01
Grade 2-vs-Grade 4
5.476000E-01
Grade 3-vs-Grade 4
9.902400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.911400E-01
Normal-vs-NonDiabetic
5.623400E-01
Diabetic-vs-NonDiabetic
7.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.866000E-01
Normal-vs-NoPancreatitis
6.045200E-01
Pancreatitis-vs-NoPancreatitis
7.175600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.643000E-01
Normal-vs-N1
7.203600E-01
N0-vs-N1
2.487000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.328600E-01
Normal-vs-TP53-NonMutant
3.132400E-01
TP53-Mutant-vs-TP53-NonMutant
5.340300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
